InsidersTradesSigma
Discover the detailed record of transactions filed by PETERSON TYCHO, Chief Financial Officer. Director active across 1 companies, notably Adaptive Biotechnologies Corp. In total, 1 disclosures have been published. The latest transaction was filed on 1 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Tycho Peterson is the Chief Financial Officer at Adaptive Biotechnologies Corp. He oversees the financial management of the company, including financial planning, analysis, and risk management. His role is essential in ensuring the financial health of the organization and supporting its growth objectives. With extensive expertise in finance, he contributes to strategic decision-making that fosters innovation in the biotechnology sector.